Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 223


Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I study.

Pappot H, von der Maase H, Ullén A, Agerbæk M; NUCOG - Nordic Urothelial Cancer Oncology Group (NUCOG).

Invest New Drugs. 2018 Aug;36(4):615-618. doi: 10.1007/s10637-017-0528-y. Epub 2017 Oct 28.


Causes of Hospital Admissions in Domus: A Randomized Controlled Trial of Specialized Palliative Cancer Care at Home.

Skov Benthien K, Nordly M, von Heymann-Horan A, Rosengaard Holmenlund K, Timm H, Kurita GP, Johansen C, Kjellberg J, von der Maase H, Sjøgren P.

J Pain Symptom Manage. 2018 Mar;55(3):728-736. doi: 10.1016/j.jpainsymman.2017.10.007. Epub 2017 Oct 19.


Dyadic psychological intervention for patients with cancer and caregivers in home-based specialized palliative care: The Domus model.

von Heymann-Horan AB, Puggaard LB, Nissen KG, Benthien KS, Bidstrup P, Coyne J, Johansen C, Kjellberg J, Nordly M, Sjøgren P, Timm H, von der Maase H, Guldin MB.

Palliat Support Care. 2018 Apr;16(2):189-197. doi: 10.1017/S1478951517000141. Epub 2017 Mar 30.


Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma.

Mortensen MS, Bandak M, Kier MG, Lauritsen J, Agerbaek M, Holm NV, von der Maase H, Daugaard G.

Cancer. 2017 Apr 1;123(7):1212-1218. doi: 10.1002/cncr.30458. Epub 2016 Nov 28.


Late Relapses in Stage I Testicular Cancer Patients on Surveillance.

Mortensen MS, Lauritsen J, Kier MG, Bandak M, Appelt AL, Agerbæk M, Holm NV, Kempel MM, von der Maase H, Daugaard G.

Eur Urol. 2016 Aug;70(2):365-71. doi: 10.1016/j.eururo.2016.03.016. Epub 2016 Mar 17.


Classification of a palliative care population in a comprehensive cancer centre.

Benthien KS, Nordly M, Videbæk K, Kurita GP, von der Maase H, Timm H, Simonsen MK, Johansen C, Sjøgren P.

Support Care Cancer. 2016 Apr;24(4):1865-73. doi: 10.1007/s00520-015-2979-z. Epub 2015 Oct 13.


uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder--Possible Clinical Implications.

Dohn LH, Pappot H, Iversen BR, Illemann M, Høyer-Hansen G, Christensen IJ, Thind P, Salling L, von der Maase H, Laerum OD.

PLoS One. 2015 Aug 20;10(8):e0135824. doi: 10.1371/journal.pone.0135824. eCollection 2015.


Reply to C. Rusner et al, L.C. Pagliaro et al, and K. Lu.

Daugaard G, Kier MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Jarle Christensen I, Lauritsen J.

J Clin Oncol. 2015 Jul 10;33(20):2326-7. doi: 10.1200/JCO.2015.60.9313. Epub 2015 Jun 1. No abstract available.


Surgery After Relapse in Stage I Nonseminomatous Testicular Cancer.

Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth MR, von der Maase H, Jarle Christensen I, Lauritsen J.

J Clin Oncol. 2015 Jul 10;33(20):2322. doi: 10.1200/JCO.2014.60.2177. Epub 2015 Jun 1. No abstract available.


Increasing international efforts to understand and conquer testicular germ cell cancer.

Rajpert-De Meyts E, Daugaard G, Almstrup K, Jørgensen A, Rørth M, Jørgensen N, von der Maase H, Skakkebaek NE.

Andrology. 2015 Jan;3(1):1-3. doi: 10.1111/andr.12010. No abstract available.


Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.

Dohn LH, Illemann M, Høyer-Hansen G, Christensen IJ, Hostmark J, Litlekalsoy J, von der Maase H, Pappot H, Laerum OD.

Urol Oncol. 2015 Apr;33(4):165.e15-24. doi: 10.1016/j.urolonc.2014.12.001. Epub 2015 Jan 6.


Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.

Kier MG, Lauritsen J, Almstrup K, Mortensen MS, Toft BG, Rajpert-De Meyts E, Skakkebaek NE, Rørth M, von der Maase H, Agerbaek M, Holm NV, Andersen KK, Dalton SO, Johansen C, Daugaard G.

Ann Oncol. 2015 Apr;26(4):737-42. doi: 10.1093/annonc/mdu585. Epub 2014 Dec 26.


Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.

Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Christensen IJ, Lauritsen J.

J Clin Oncol. 2014 Dec 1;32(34):3817-23. doi: 10.1200/JCO.2013.53.5831. Epub 2014 Sep 29.


The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home.

Nordly M, Benthien KS, Von Der Maase H, Johansen C, Kruse M, Timm H, Vadstrup ES, Kurita GP, von Heymann-Horan AB, Sjøgren P.

BMC Palliat Care. 2014 Sep 9;13:44. doi: 10.1186/1472-684X-13-44. eCollection 2014.


A nationwide cohort study of stage I seminoma patients followed on a surveillance program.

Mortensen MS, Lauritsen J, Gundgaard MG, Agerbæk M, Holm NV, Christensen IJ, von der Maase H, Daugaard G.

Eur Urol. 2014 Dec;66(6):1172-8. doi: 10.1016/j.eururo.2014.07.001. Epub 2014 Jul 23.


Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia.

Carus A, Gurney H, Gebski V, Harnett P, Hui R, Kefford R, Wilcken N, Ladekarl M, von der Maase H, Donskov F.

J Transl Med. 2013 Aug 15;11:189. doi: 10.1186/1479-5876-11-189.


Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.

Brandberg Y, Johansson H, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J; Nordic Melanoma Cooperative Group.

Acta Oncol. 2013 Aug;52(6):1086-93. doi: 10.3109/0284186X.2013.789140. Epub 2013 Apr 28.


Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy.

Bellmunt J, Fougeray R, Rosenberg JE, von der Maase H, Schutz FA, Salhi Y, Culine S, Choueiri TK.

Ann Oncol. 2013 Jun;24(6):1466-72. doi: 10.1093/annonc/mdt007. Epub 2013 Feb 17.


Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma.

Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD, Sonpavde G.

Clin Genitourin Cancer. 2013 Sep;11(3):316-20. doi: 10.1016/j.clgc.2012.12.007. Epub 2013 Jan 16.


Supplemental Content

Loading ...
Support Center